Cellular Therapy:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Ashland :
Delve Publishing,
2019.
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Beschreibung: | 7.8. Regeneration of Pancreatic Islets |
| Beschreibung: | 1 online resource (321 pages) |
| ISBN: | 1773617648 9781773617640 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1085170390 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 190209s2019 xx o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d YDX |d OCLCQ |d UKAHL |d N$T |d OCLCO |d OCLCF |d OCLCO |d K6U |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 019 | |a 1084493957 |a 1084674021 |a 1284940348 | ||
| 020 | |a 1773617648 | ||
| 020 | |a 9781773617640 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1085170390 |z (OCoLC)1084493957 |z (OCoLC)1084674021 |z (OCoLC)1284940348 | ||
| 050 | 4 | |a RM301.37 | |
| 082 | 7 | |a 615.5 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Gautam, Shraddha. | |
| 245 | 1 | 0 | |a Cellular Therapy |
| 260 | |a Ashland : |b Delve Publishing, |c 2019. | ||
| 300 | |a 1 online resource (321 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies | |
| 505 | 8 | |a 2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven | |
| 505 | 8 | |a 3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering | |
| 505 | 8 | |a 4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells | |
| 505 | 8 | |a 6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells | |
| 500 | |a 7.8. Regeneration of Pancreatic Islets | ||
| 650 | 0 | |a Cellular therapy. |0 http://id.loc.gov/authorities/subjects/sh85021700 | |
| 650 | 2 | |a Cell- and Tissue-Based Therapy |0 https://id.nlm.nih.gov/mesh/D064987 | |
| 650 | 6 | |a Thérapie cellulaire. | |
| 650 | 7 | |a Cellular therapy |2 fast | |
| 700 | 1 | |a Priyadarshini, Anjali. | |
| 700 | 1 | |a Pandey, Prerna. | |
| 776 | 0 | 8 | |i Print version: |a Gautam, Shraddha. |t Cellular Therapy. |d Ashland : Delve Publishing, ©2019 |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2013979 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2013979 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n BDZ0044472782 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL5655585 | ||
| 938 | |a EBSCOhost |b EBSC |n 2013979 | ||
| 938 | |a YBP Library Services |b YANK |n 16023390 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1085170390 |
|---|---|
| _version_ | 1826942282187669504 |
| adam_text | |
| any_adam_object | |
| author | Gautam, Shraddha |
| author2 | Priyadarshini, Anjali Pandey, Prerna |
| author2_role | |
| author2_variant | a p ap p p pp |
| author_facet | Gautam, Shraddha Priyadarshini, Anjali Pandey, Prerna |
| author_role | |
| author_sort | Gautam, Shraddha |
| author_variant | s g sg |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.37 |
| callnumber-search | RM301.37 |
| callnumber-sort | RM 3301.37 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| collection | ZDB-4-EBA |
| contents | Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies 2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven 3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering 4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells 6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells |
| ctrlnum | (OCoLC)1085170390 |
| dewey-full | 615.5 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.5 |
| dewey-search | 615.5 |
| dewey-sort | 3615.5 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04728cam a2200517Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1085170390</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |n|---|||||</controlfield><controlfield tag="008">190209s2019 xx o 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">EBLCP</subfield><subfield code="d">YDX</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKAHL</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1084493957</subfield><subfield code="a">1084674021</subfield><subfield code="a">1284940348</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1773617648</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781773617640</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1085170390</subfield><subfield code="z">(OCoLC)1084493957</subfield><subfield code="z">(OCoLC)1084674021</subfield><subfield code="z">(OCoLC)1284940348</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM301.37</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.5</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gautam, Shraddha.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cellular Therapy</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Ashland :</subfield><subfield code="b">Delve Publishing,</subfield><subfield code="c">2019.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (321 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">7.8. Regeneration of Pancreatic Islets</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cellular therapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85021700</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Cell- and Tissue-Based Therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D064987</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Thérapie cellulaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cellular therapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Priyadarshini, Anjali.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pandey, Prerna.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Gautam, Shraddha.</subfield><subfield code="t">Cellular Therapy.</subfield><subfield code="d">Ashland : Delve Publishing, ©2019</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2013979</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2013979</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">BDZ0044472782</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL5655585</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2013979</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">16023390</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1085170390 |
| illustrated | Not Illustrated |
| indexdate | 2025-03-18T14:25:32Z |
| institution | BVB |
| isbn | 1773617648 9781773617640 |
| language | English |
| oclc_num | 1085170390 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (321 pages) |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Delve Publishing, |
| record_format | marc |
| spelling | Gautam, Shraddha. Cellular Therapy Ashland : Delve Publishing, 2019. 1 online resource (321 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Print version record. Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies 2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven 3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering 4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells 6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells 7.8. Regeneration of Pancreatic Islets Cellular therapy. http://id.loc.gov/authorities/subjects/sh85021700 Cell- and Tissue-Based Therapy https://id.nlm.nih.gov/mesh/D064987 Thérapie cellulaire. Cellular therapy fast Priyadarshini, Anjali. Pandey, Prerna. Print version: Gautam, Shraddha. Cellular Therapy. Ashland : Delve Publishing, ©2019 |
| spellingShingle | Gautam, Shraddha Cellular Therapy Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies 2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven 3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering 4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells 6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells Cellular therapy. http://id.loc.gov/authorities/subjects/sh85021700 Cell- and Tissue-Based Therapy https://id.nlm.nih.gov/mesh/D064987 Thérapie cellulaire. Cellular therapy fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85021700 https://id.nlm.nih.gov/mesh/D064987 |
| title | Cellular Therapy |
| title_auth | Cellular Therapy |
| title_exact_search | Cellular Therapy |
| title_full | Cellular Therapy |
| title_fullStr | Cellular Therapy |
| title_full_unstemmed | Cellular Therapy |
| title_short | Cellular Therapy |
| title_sort | cellular therapy |
| topic | Cellular therapy. http://id.loc.gov/authorities/subjects/sh85021700 Cell- and Tissue-Based Therapy https://id.nlm.nih.gov/mesh/D064987 Thérapie cellulaire. Cellular therapy fast |
| topic_facet | Cellular therapy. Cell- and Tissue-Based Therapy Thérapie cellulaire. Cellular therapy |
| work_keys_str_mv | AT gautamshraddha cellulartherapy AT priyadarshinianjali cellulartherapy AT pandeyprerna cellulartherapy |